Watson Pharmaceuticals Inc. (WPI) posted third quarter net income of $63.0 million, or $0.55 per diluted share, compared to $71.1 million or $0.62 per share in the prior year quarter.
Excluding special items, adjusted net income for the quarter was $76.1 million or $0.66 per share, compared to $54.0 million or $0.47 per share in last year quarter.
On average, 15 analysts polled by Thomson Reuters expected the company to report earnings of $0.65 per share. Analysts' estimates typically exclude special items.
Net revenue for the quarter was $662.1 million, compared to $640.7 million last year. Fourteen Wall Street analysts expected revenues of $688.53 million.
Looking forward, for the fiscal year 2009, Watson now estimates GAAP earnings per share in the range of between $2.04 and $2.12, compared to its previous forecast range of $2.13 to $2.21. The company affirms 2009 Adjusted earnings per share to range between $2.50 and $2.58. Street analysts expect earnings of $2.55 per share.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.